90/012,668PROCESS FOR THE PURIFICATION OF DULOXETINE HYDROCHLORIDE7,534,900Closed

Status

Reexamination Certificate Issued

Filed

Sep 15, 2012

Last Updated

Aug 27, 2013

Art Unit

3991

Requester Law Firm

Unknown

Requested By

Third Party

Patent OwnerInferred

Teva Pharmaceuticals USA Inc.

Sector (CPC)

CChemistry & Materials
C07Organic Chemistry
C07DHeterocyclic Compounds

USPC

549Organic Compounds

Reexam History (22 events)

Aug 27, 2013REEXInput Issue Number and Issue Date for Reexamination
Aug 14, 2013RXPUBSReexam Forwarded to Office of Publications
Aug 9, 2013MRNRCRX - Mail Notice of Intent to Issue a Reexam Certificate
Aug 5, 2013RXLITSRReexam Litigation Search Conducted
Feb 13, 2013RXFWDXDate Forwarded to Examiner
Feb 12, 2013NRX.Notice of Reexam Published in Official Gazette
Dec 6, 2012MREXORX - Mail Ex Parte Request for Reexamination Granted
Dec 6, 2012MR.NFRX - Mail Reexam Non-Final Action
Oct 29, 2012MREXNRX - Mail Examiner Interview Summary Record
Oct 26, 2012RXWVSTWaiver of owners statement in ex parte
Oct 24, 2012MRXNReexamination Formalities Notice Mailed
Oct 24, 2012ROIPEApplication Return TO OIPE
Oct 24, 2012MRXNReexamination Formalities Notice Mailed
Oct 24, 2012WROIPEApplication Return from OIPE
Oct 23, 2012DOCKCase Docketed to Examiner in GAU
Oct 22, 2012RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Oct 22, 2012RXNREQAUNotice of assignment of reexamination request
Oct 22, 2012RXTTLRPTTitle Report
Oct 22, 2012RXNREQFDNotice of reexamination request filing date
Sep 15, 2012RXOSUBReceipt of Original Ex Parte Reexam Request
Sep 15, 2012RXOSUB.RReexamination requested by third party requester
Sep 15, 2012RXIDS.Information Disclosure Statement Filed

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

None found

Prosecution History

None found

Maintenance Fees

Grant
May 19, 2009
3.5-yr
Nov 19, 2012
7.5-yr
Nov 19, 2016
11.5-yr
Nov 19, 2020
Expiry
Apr 13, 2026

Entity Status

Large Entity

Expires

Apr 13, 2026 (expired)

Term Adjustment

+30 days (~0.1 yr)

Other

USPTO Event: Expire PatentUSPTO Event: Maintenance Fee Reminder Mailed

Assignments

Apr 2006May 2006Jun 2006Jul 2006FiledSANTIAGO INIMILI ABRAMOVANITA LIBERMANTEVA PHARMACEUTICAL INDUSTRIES LTDTEVA PHARMACEUTICALS USA, INC.
AssignmentReel/Frame: 018076/0084Recorded: Aug 8, 2006

From

MILI ABRAMOVInventor
Jun 21, 2006
SANTIAGO INIInventor
Jun 8, 2006
ANITA LIBERMANInventor
Jun 21, 2006

To

TEVA PHARMACEUTICAL INDUSTRIES LTD

AssignmentReel/Frame: 018076/0153Recorded: Aug 8, 2006

From

TEVA PHARMACEUTICAL INDUSTRIES LTD
Jul 19, 2006

To

TEVA PHARMACEUTICALS USA, INC.